Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Synergy Pharmaceuticals, Inc.
Synergy Pharmaceuticals shares surged 18 percent on over 8 times the average daily volume Wednesday. The company has reported that plecanatide, their treatment for chronic idiopathic constipation, met the primary and key secondary endpoints of a Phase IIb/III clinical study.
Going forward ... (see research report)
Subscribe to News Feeds